These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25580204)

  • 21. (Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.
    Sharma SK; Wu Y; Steinbergs N; Crowley ML; Hanson AS; Casero RA; Woster PM
    J Med Chem; 2010 Jul; 53(14):5197-212. PubMed ID: 20568780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
    Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
    J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis.
    Kumarasinghe IR; Woster PM
    Eur J Med Chem; 2018 Mar; 148():210-220. PubMed ID: 29459279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells.
    Zhu Q; Huang Y; Marton LJ; Woster PM; Davidson NE; Casero RA
    Amino Acids; 2012 Feb; 42(2-3):887-98. PubMed ID: 21805138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.
    Yang M; Culhane JC; Szewczuk LM; Jalili P; Ball HL; Machius M; Cole PA; Yu H
    Biochemistry; 2007 Jul; 46(27):8058-65. PubMed ID: 17569509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1.
    Dai XJ; Liu Y; Xue LP; Xiong XP; Zhou Y; Zheng YC; Liu HM
    J Med Chem; 2021 Mar; 64(5):2466-2488. PubMed ID: 33619958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances of LSD1/KDM1A inhibitors for disease therapy.
    Zhang C; Wang Z; Shi Y; Yu B; Song Y
    Bioorg Chem; 2023 May; 134():106443. PubMed ID: 36857932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.
    Dai XJ; Liu Y; Xiong XP; Xue LP; Zheng YC; Liu HM
    J Med Chem; 2020 Dec; 63(23):14197-14215. PubMed ID: 32931269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021.
    Song Y; Zhang H; Yang X; Shi Y; Yu B
    Eur J Med Chem; 2022 Jan; 228():114042. PubMed ID: 34915312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of natural product-like spirooxindole derivatives as highly potent and selective LSD1/KDM1A inhibitors for AML treatment.
    Yang C; Fang Y; Luo X; Teng D; Liu Z; Zhou Y; Liao G
    Bioorg Chem; 2022 Mar; 120():105596. PubMed ID: 35051709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes.
    El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H
    Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone demethylase LSD1 regulates bone mass by controlling WNT7B and BMP2 signaling in osteoblasts.
    Sun J; Ermann J; Niu N; Yan G; Yang Y; Shi Y; Zou W
    Bone Res; 2018; 6():14. PubMed ID: 29707403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation.
    Liang L; Wang H; Du Y; Luo B; Meng N; Cen M; Huang P; Ganesan A; Wen S
    Bioorg Chem; 2020 Jun; 99():103808. PubMed ID: 32334189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment.
    Ma QS; Zhang YF; Li CY; Zhang WX; Yuan L; Niu JB; Song J; Zhang SY; Liu HM
    Eur J Med Chem; 2023 May; 251():115228. PubMed ID: 36881982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Update of Lysine Specific Demethylase 1 Inhibitor: A Patent Review (2016-2020).
    Zheng YC; Liu YJ; Gao Y; Wang B; Liu HM
    Recent Pat Anticancer Drug Discov; 2022; 17(1):9-25. PubMed ID: 34323202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.
    Mimasu S; Sengoku T; Fukuzawa S; Umehara T; Yokoyama S
    Biochem Biophys Res Commun; 2008 Feb; 366(1):15-22. PubMed ID: 18039463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A.
    Vianello P; Botrugno OA; Cappa A; Ciossani G; Dessanti P; Mai A; Mattevi A; Meroni G; Minucci S; Thaler F; Tortorici M; Trifiró P; Valente S; Villa M; Varasi M; Mercurio C
    Eur J Med Chem; 2014 Oct; 86():352-63. PubMed ID: 25173853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.
    Murray-Stewart T; Woster PM; Casero RA
    Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.
    Schmidt DM; McCafferty DG
    Biochemistry; 2007 Apr; 46(14):4408-16. PubMed ID: 17367163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysine-Specific Demethylase 1 (LSD1) epigenetically controls osteoblast differentiation.
    Rummukainen P; Tarkkonen K; Dudakovic A; Al-Majidi R; Nieminen-Pihala V; Valensisi C; Hawkins RD; van Wijnen AJ; Kiviranta R
    PLoS One; 2022; 17(3):e0265027. PubMed ID: 35255108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.